Projects See all
Latest Articles See all
National Institutes of Health recently published a catastrophically flawed case report on kratom, with multiple references which directly contradict the paper’s conclusions, and one source that simply doesn’t exist.
On August 30th, the DEA filed a notice of intent to temporarily designate Kratom as a schedule 1 drug. That notice listed 33 footnotes, but the actual references themselves were not included in the document itself. The same day, a FOIA was filed for that information … to which the agency responded with with press releases and copies of federal laws.
Latest Requests See all
|FDA: Copies of Documents Provided to Senator McCaskill||Awaiting Acknowledgement||Food and Drug Administration||United States of America|
|OCC: Operation Choke Point||Awaiting Acknowledgement||Office of the Comptroller of the Currency||United States of America|
|FDIC: Operation Choke Point||Awaiting Response||Federal Deposit Insurance Corporation||United States of America|
|DOJ: Operation Choke Point||Fix Required||Department of Justice||United States of America|
|FDA: Phenylpiracetam (aka Phenotropil or Carphedon)||Awaiting Acknowledgement||Food and Drug Administration||United States of America|